Antiretroviral Therapy for the Prevention of HIV-1 TransmissionMyron S. Cohen, Thomas R. Fleming, Joseph J. Eron et al.|New England Journal of Medicine|2016Cited by 1.7k
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical TrialRami Kantor, Susan H. Eshleman, Laura Smeaton et al.|Clinical Infectious Diseases|2015Cited by 80
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn, Michael D. Hughes, Justin Ritz et al.|The Lancet HIV|2019Cited by 39
Evaluation of Phylogenetic Methods for Inferring the Direction of Human Immunodeficiency Virus (HIV) Transmission: HIV Prevention Trials Network (HPTN) 052Yinfeng Zhang, Susan H. Eshleman, Chris Wymant et al.|Clinical Infectious Diseases|2020Cited by 34
Prevention of HIV-1 Infection with Early Antiretroviral TherapyHeather J. Ribaudo, David D. Celentano, Joseph J. Eron et al.|UNC Libraries|2020Cited by 28